Peer-reviewedCC BY-NC-NDEuropean journal of pain (London, England)
Response to Andrea Truini: Diagnosing a Lesion or Diagnosing Neuropathic Pain?
- 1Inserm U987, Ambroise Pare Hospital, UVSQ-Paris-Saclay University, Boulogne-Billancourt, France.
Related
- Lesion Without Pain, Pain Without Certainty: A Critical Reappraisal of the NeuPSIG Diagnostic Algorithm for Neuropathic Pain
- Predictors of methadone response in chronic neuropathic pain
- The Role of Dominant Lesion Site and SUVmax in the Depth of PSA Response in Metastatic Hormone-Sensitive Prostate Cancer
- Cytokine Profiles in Cervical Intraepithelial Neoplasia: Associations with Lesion Severity and Exploratory Treatment Response
- Early Sensory Dysfunction in Type 2 Diabetes: Vibration Perception Abnormalities in Patients Without Neuropathic Symptoms
BibTeX
@article{bouhassira2026response,
title = {{Response to Andrea Truini: Diagnosing a Lesion or Diagnosing Neuropathic Pain?}},
author = {Didier Bouhassira and Nadine Attal},
journal = {European journal of pain (London, England)},
year = {2026},
month = oct,
doi = {10.1002/ejp.70435},
url = {https://europepmc.org/article/MED/42902819},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Response to Andrea Truini: Diagnosing a Lesion or Diagnosing Neuropathic Pain?
AU - Didier Bouhassira
AU - Nadine Attal
PY - 2026
DA - 2026/10/30
JO - European journal of pain (London, England)
DO - 10.1002/ejp.70435
UR - https://europepmc.org/article/MED/42902819
SN - 1090-3801
SN - 1532-2149
ER -